These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33251149)

  • 1. Technical Advancements for Studying Immune Regulation of Disseminated Dormant Cancer Cells.
    Ombrato L; Montagner M
    Front Oncol; 2020; 10():594514. PubMed ID: 33251149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
    Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
    Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How much do we know about the metastatic process?
    Rodriguez-Tirado C; Sosa MS
    Clin Exp Metastasis; 2024 Aug; 41(4):275-299. PubMed ID: 38520475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Dormancy and Reactivation in Bone Marrow.
    Singh DK; Patel VG; Oh WK; Aguirre-Ghiso JA
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34208521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic and Pluripotency Aspects of Disseminated Cancer Cells During Minimal Residual Disease.
    Carlini MJ; Shrivastava N; Sosa MS
    Adv Exp Med Biol; 2018; 1100():1-18. PubMed ID: 30411257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.
    Calvo V; Zheng W; Adam-Artigues A; Staschke KA; Huang X; Cheung JF; Nobre AR; Fujisawa S; Liu D; Fumagalli M; Surguladze D; Stokes ME; Nowacek A; Mulvihill M; Farias EF; Aguirre-Ghiso JA
    Clin Cancer Res; 2023 Dec; 29(24):5155-5172. PubMed ID: 37982738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
    Weidenfeld K; Barkan D
    Front Oncol; 2018; 8():381. PubMed ID: 30258818
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Montagner M; Sahai E
    Front Cell Dev Biol; 2020; 8():37. PubMed ID: 32195244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications.
    Robinson NJ; Parker KA; Schiemann WP
    Ann Transl Med; 2020 Jul; 8(14):903. PubMed ID: 32793747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
    De Angelis ML; Francescangeli F; Zeuner A
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Innate Immune System in Cancer Dormancy and Relapse.
    Chernosky NM; Tamagno I
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-intrinsic survival signals. The role of autophagy in metastatic dissemination and tumor cell dormancy.
    Vera-Ramirez L
    Semin Cancer Biol; 2020 Feb; 60():28-40. PubMed ID: 31400500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
    Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
    Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dormant cancer cells: programmed quiescence, senescence, or both?
    Truskowski K; Amend SR; Pienta KJ
    Cancer Metastasis Rev; 2023 Mar; 42(1):37-47. PubMed ID: 36598661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung.
    Nobre AR; Dalla E; Yang J; Huang X; Wullkopf L; Risson E; Razghandi P; Anton ML; Zheng W; Seoane JA; Curtis C; Kenigsberg E; Wang J; Aguirre-Ghiso JA
    Nat Cancer; 2022 Oct; 3(10):1165-1180. PubMed ID: 36050483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.
    Marlow R; Dontu G
    Methods Mol Biol; 2015; 1293():213-20. PubMed ID: 26040690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dormancy dilemma: quiescence versus balanced proliferation.
    Wells A; Griffith L; Wells JZ; Taylor DP
    Cancer Res; 2013 Jul; 73(13):3811-6. PubMed ID: 23794703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer and dormant metastases: Put to sleep or destroy?
    Senchukova MA
    World J Gastrointest Oncol; 2024 Jun; 16(6):2304-2317. PubMed ID: 38994146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.
    Yadav AS; Pandey PR; Butti R; Radharani NNV; Roy S; Bhalara SR; Gorain M; Kundu GC; Kumar D
    Front Oncol; 2018; 8():72. PubMed ID: 29616190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.
    Eyles J; Puaux AL; Wang X; Toh B; Prakash C; Hong M; Tan TG; Zheng L; Ong LC; Jin Y; Kato M; Prévost-Blondel A; Chow P; Yang H; Abastado JP
    J Clin Invest; 2010 Jun; 120(6):2030-9. PubMed ID: 20501944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.